Which hedge funds own OLMA? OLEMA PHARMACEUTICALS INC, Q2 2026 13F holders
36 tracked hedge funds disclosed a position in OLMA (OLEMA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $351.5m in total. The largest holder by portfolio weight is Paradigm Biocapital Advisors LP at 2.0% of its book. 10 opened a new position this quarter: Jones Hill Capital LP, Readystate Asset Management LP, Deep Track Capital, LP, Seven Fleet Capital Management LP. 13 exited: RA Capital Management, L.P., ACT Capital Management, LLC, Polar Capital Holdings Plc.
- 36
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 10
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 13
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $35.4m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $77.1m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $352m
- Combined value Sum of the holders' reported positions in the security.
- 2.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| RA Capital Management, L.P. | 0.4% | $38.8m |
| ACT Capital Management, LLC | 0.3% | $373k |
| Polar Capital Holdings Plc | 0.1% | $23.9m |
| Burkehill Global Management, LP | 0.09% | $1.9m |
| Aquatic Capital Management LLC | 0.05% | $1.7m |
| Y-Intercept (Hong Kong) Ltd | 0.03% | $1.3m |
| PDT Partners, LLC | 0.01% | $228k |
| Entropy Technologies, LP | 0.01% | $235k |
| Graham Capital Management, L.P. | 0.01% | $249k |
| Adage Capital Partners GP, L.L.C. | 0.01% | $4.1m |
| Balyasny Asset Management L.P. | 0.0% | $1.3m |
| Millennium Management LLC | 0.0% | $2.7m |
| Walleye Capital LLC | 0.0% | $317k |
Ownership over time
Who discovered OLMA first? Beta
The run: Q4 2022 → Q4 2023, +473%
| Paradigm Biocapital Advisors LP high conviction | Q3 2023 | – | +3.0 pts |
| Silverarc Capital Management, LLC | Q3 2023 | – | +1.7 pts |
| Great Point Partners LLC | Q2 2021 | – | +0.1 pts |
| Fairmount Funds Management LLC | Q1 2022 | 0.6% | −0.9 pts |
| RA Capital Management, L.P. | Q4 2020 | – | −1.6 pts |
| Cormorant Asset Management, LP | Q4 2020 | 0.3% | −4.8 pts |
| Logos Global Management LP high conviction | Q4 2020 | 1.1% | −7.9 pts |
| Venrock Adviser, LLC high conviction | Q4 2020 | – | −7.9 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.